My bookmarksSign up free
Source

Commission Implementing Decision (EU) 2020/452 of 26 March 2020 amending Implementing Decision (EU) 2019/570 as regards capacities established to respond to low probability risks with a high impact (notified under document C(2020) 2011) (Text with EEA relevance)

Commission Implementing Decision (EU) 2020/452 of 26 March 2020 amending Implementing Decision (EU) 2019/570 as regards capacities established to respond to low probability risks with a high impact (notified under document C(2020) 2011) (Text with EEA relevance)

Implementing Decision (EU) 2020/452 · Decision · 2 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Categories of low probability risks with a high impact

Article 1

Open ↗

Implementing Decision (EU) 2019/570 is amended as follows: (1) Article 1 is amended as follows: (a) point (e) is replaced by the following: ‘(e) total estimated costs of medical stockpiling rescEU capacities;’; (b) the following points (f) and (g) are added: ‘(f) the categories of low probability risks with a high impact; (g) the rescEU capacities established to manage low probability risks with a high impact.’; (2) the following Articles are inserted: ‘Article 3d Categories of low probability risks with a high impact For the purposes of establishing rescEU capacities necessary to respond to low probability risks with a high impact, the Commission shall take the following into account: (a) the unpredictability or the extraordinary nature of a disaster; (b) the scale of a disaster, including mass casualties, mass fatalities, and mass displacement; (c) the protracted duration of a disaster; (d) the degree of complexity of a disaster; (e) the potential risk of severely disrupting the functioning of the national government, including the provision of social, environmental, economic and public health services or the disruption of critical infrastructure referred to in Article 2(a) of Council Directive 2008/114/EC  ( *1 ) ; (f) geographical range, including the potential of impacts spreading beyond borders; (g) other factors such as the activation in full mode of the Integrated Political Crisis Response (IPCR) arrangements of the Council or the invocation of the solidarity clause pursuant to Article 222 of the Treaty on the Functioning of the European Union. Article 3e rescEU capacities established to respond to low probability risks with a high impact 1.   Capacities corresponding to events characterised by at least two of the categories, as specified in Article 3d, shall be established with the objective of responding to low probability risks with a high impact. 2.   For every defined rescEU capacity under Article 2(2), the Commission shall consider whether the capacity can be established to respond to low probability risks with a high impact. 3.   rescEU capacities referred to in points (c), (d), (e) and (f) under Article 2(2) shall be established with the objective of managing low probability risks with a high impact. Union financial assistance shall cover all costs necessary to ensure their availability and deployability, in accordance with Article 21(4) of Decision No 1313/2013/EU. 4.   Where rescEU capacities referred to in points (c), (d), (e) and (f) under Article 2(2) are deployed under the Union Mechanism, Union financial assistance shall cover 100 % of the operational costs, in accordance with Article 23(4b) of Decision No 1313/2013/EU. ( *1 )   Council Directive 2008/114/EC of 8 December 2008 on the identification and designation of European critical infrastructures and the assessment of the need to improve their protection ( OJ L 345, 23.12.2008, p. 75 ).’ "

Addressees

Article 2

Open ↗

This Decision is addressed to the Member States. It shall apply from 19 March 2020.

Other acts of the same type
Commission Implementing Decision (EU) 2026/1126 of 26 May 2026 concerning the extension of the action taken by the Malta Competition and Consumer Affairs Authority permitting the making available on the market and use of the biocidal product Wofasteril® SC super in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2026) 3265)Commission Implementing Decision (EU) 2026/1135 of 26 May 2026 on the clearance of the accounts of the paying agencies of Member States concerning expenditure within the CAP Strategic Plan financed by the European Agricultural Fund for Rural Development (EAFRD) in the period 2023-2027 for the financial year 2025 (notified under document C(2026) 3341)Commission Implementing Decision (EU) 2026/1137 of 26 May 2026 on the clearance of the accounts of the paying agencies of Member States concerning expenditure financed by the European Agricultural Guarantee Fund (EAGF) for the financial year 2025 (notified under document C(2026) 3359)Council Decision (CFSP) 2026/1149 of 26 May 2026 amending Decision (CFSP) 2024/1484 concerning restrictive measures in view of the situation in RussiaCommission Implementing Decision (EU) 2026/1182 of 26 May 2026 concerning the extension of the action taken by the Hungarian National Center for Public Health and Pharmacy permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2026) 3295)Council Decision of 22 May 2026 replacing a member of the Management Board of the European Centre for the Development of Vocational Training (Cedefop) for CyprusCouncil Decision of 22 May 2026 appointing a member of the European Statistical Governance Advisory BoardCouncil Decision of 22 May 2026 replacing a member of the Management Board of the European Centre for the Development of Vocational Training (Cedefop) for SlovakiaCouncil Decision of 22 May 2026 appointing a member of the European Statistical Governance Advisory BoardCommission Implementing Decision (EU) 2026/1103 of 22 May 2026 postponing the expiry date of the approval of PHMB (1415; 4.7) for use in biocidal products of product-types 2 and 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/1104 of 22 May 2026 concerning the extension of the action taken by the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2026) 3259)Commission Implementing Decision (EU) 2026/1109 of 22 May 2026 postponing the expiry date of the approval of glutaraldehyde for use in biocidal products of product-types 2, 3, 4, 6, 11 and 12 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next